Buspirone hydrochloride
- Product NDC
- 50268-135
- 11-digit product format
- 502680135
- Labeler code
- 50268
- Product ID
- 50268-135_4c3657a8-f6bd-b2a4-e063-6394a90a741d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Buspirone hydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- AvPAK
- Application
- ANDA078888
- Marketing category
- ANDA
- Marketing start
- 2020-10-21
- Substance
- BUSPIRONE HYDROCHLORIDE
- Active strength
- 15 mg/1
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Buspirone hydrochloride
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| BUSPIRONE HYDROCHLORIDE | 15 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 207LT9J9OC |
| Rxcui | 866018 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 50268-135-11 | Buspirone hydrochloride | 1 in 1 BLISTER PACK | TABLET | 1 | | 6 |
| 50268-135-15 | Buspirone hydrochloride | 50 in 1 BOX | TABLET | 50 | | 6 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50268-135 | BUSPIRONE HYDROCHLORIDE TABLET [AVPAK] | 4 | Current NDC, Legacy NDC, 2 package rows | 20240110_b230197c-3d50-7874-e053-2a95a90af50f.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50268-135-11 | 50268013511 | 1 in 1 BLISTER PACK | | | | | | Historical |
| 50268-135-15 | 50268013515 | 50 BLISTER PACK in 1 BOX (50268-135-15) / 1 TABLET in 1 BLISTER PACK (50268-135-11) | 50 blister pack | 2020-10-21 | 0000-00-00 | No | No | Current |